Contract Manufacturing Organization Companies - Top Contract Manufacturing Organizations

Pharma Tech Outlook: Pharma Tech Magazine

Andelyn Biosciences: The Complete Package for Gene Therapy

Top 10 Contract Manufacturing Organizations - 2022


The one-stop shop concept is swiftly gaining traction in the contract manufacturing landscape. As pharma innovators increasingly integrate CMOs and CDMOs across their entire development process, many providers have started offering development and manufacturing services for both active pharmaceutical ingredients (APIs) and drug products under the same roof. Notably, digital transformation is the key to bringing down the increasing R&D costs in the sector, and CMOs and CDMOs are the centerpieces of it. Amid the ongoing disruptions like the pandemic-fueled digitalization sprint, the growing sustainability demands, and the third wave of biotech, partnerships with CMOs and CDMOs have become crucial for pharma and biopharma companies to stay competitive in the market with faster drug development, cost reduction, and swift market delivery. As a result, the pharmaceutical CMO/CDMO market valued at $183.62 billion last year is projected to reach $289.64 billion by 2027, at a CAGR of 7.29 percent.

To put the spotlight on such key developments, Pharma Tech Outlook highlights the vital technological advancements in the pharmaceuticals space and how CMOs and CDMOs leverage them to augment the development lifecycles of pharma and biopharma companies. The edition features thought leadership articles from Ozgur Akbulut, Director, Global Divestments and Contract Manufacturing Lead at Takeda, and Olga Minkov, Executive Director, Operations – Pharmacovigilance and Epi at Gilead Sciences, who throw light on the recent innovations in the pharmaceutical sector.

In this edition of Pharma Tech Outlook magazine, we bring you the story of some of the top CMOs/CDMOs that deliver the best outcomes for their clients, including ABL, Ascendia Pharmaceuticals, Aspen API, AstaTech, Center for Breakthrough Medicines, Goodwin Biotechnology, and TeleTec Electronics. We also highlight TCG GreenChem, a contract innovation company that provides CDMO services with a unique modus operandi in pharmaceutical R&D, and Andelyn Biosciences, a biopharmaceutical CDMO with more than two decades of expertise in pioneering viral vector and vaccine manufacturing.

Through the following pages, we aim to shine a light on the innovative trends and latest developments in the pharmaceutical space. We would like to know your thoughts.

    Top Contract Manufacturing Organizations

  • Andelyn Biosciences supports clients as a 100 percent CDMO in Gene Therapy with diverse capabilities spanning preclinical R&D, small to large scale GMP manufacturing up to 2000L, Analytical Development and testing, and plasmid manufacturing services.

  • TCG GreenChem, Inc. is the US subsidiary of TCG Lifesciences Pvt. Ltd., (formerly “Chembiotek Research International”) a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery, development and commercialization.

  • As one of the world’s leading contract manufacturing organizations and service providers, ABL helps clients evaluate the safety and efficacy of biologics in their clinical programs. With over 25 years of viral vector development and GMP production experience, ABL’s core focus is on accelerating novel gene therapies, vaccines, oncolytics, and immunotherapies.

  • Ascendia Pharmaceuticals is a specialty CDMO dedicated to delivering sophisticated formulations of existing drug products and enabling formulations for preclinical- and clinical-stage drug candidates.

  • Aspen API carries a long-lasting experience in the development and manufacturing of complex APIs. With the extensive manufacturing network and global regulatory support, Aspen API is considered one of the best API suppliers in the market. Being a hormone/steroid producer for many years, Aspen API has learned how to produce HPAPI under very strict quality and safety regimes.

  • As one of the earliest leading pharmaceutical CRO/CMO in the US, run by veteran scientists from the pharmaceutical industry, AstaTech specializes in offering advanced intermediates, custom synthesis, FTE production, catalog products, and analytical services.

  • Center for Breakthrough Medicines (CBM) is an advanced therapy focused CDMO dedicated to delivering life-changing treatments to the patients that need them. Their end-to-end capabilities include plasmid DNA, viral vector manufacturing, and cell therapy production from pre-clinical to commercial scale, with drug substance, drug product, and analytical services all at a single site. Our team leaders were involved in commercializing the first cell & gene therapies at leading biotechs and CDMO’s, and are ready to help guide your innovations from concept to clinic to commercial.

  • Goodwin Biotechnology is a biologics contract development and manufacturing organization (CDMO) that promptly sets itself apart in the market by being nimble and delivering robust biomanufacturing solutions since 1992. Goodwin Biotechnology proffers high-quality, cost-effective, flexible, and cGMP-compliant manufacturing solutions in an efficient and timely manner to produce complex biologic therapeutics for companies across the globe.

  • TeleTec and its partners offer full-service contract manufacturing in cable assembly, plastic injection molding, precision machining, and electronics manufacturing services.

  • Catalent


    Catalent Inc. (NYSE: CTLT) is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.